메뉴 건너뛰기




Volumn 342, Issue 24, 2000, Pages 1792-1801

Plasminogen-activator inhibitor type 1 and coronary artery disease

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; FIBRIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

EID: 0034660437     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200006153422406     Document Type: Review
Times cited : (743)

References (103)
  • 1
    • 0027125530 scopus 로고
    • The pathogenesis of coronary artery disease and the acute coronary syndromes
    • Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50, 310-8.
    • (1992) N Engl J Med , vol.326 , pp. 242-250
    • Fuster, V.1    Badimon, L.2    Badimon, J.J.3    Chesebro, J.H.4
  • 2
    • 0024417535 scopus 로고
    • Coronary risk associated with age and sex of parental heart disease in the Framingham study
    • Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989;64:555-9.
    • (1989) Am J Cardiol , vol.64 , pp. 555-559
    • Schildkraut, J.M.1    Myers, R.H.2    Cupples, L.A.3    Kiely, D.K.4    Kannel, W.B.5
  • 3
    • 0021219582 scopus 로고
    • Family history as an independent risk factor for coronary artery disease
    • Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984;4:793-801.
    • (1984) J Am Coll Cardiol , vol.4 , pp. 793-801
    • Shea, S.1    Ottman, R.2    Gabrieli, C.3    Stein, Z.4    Nichols, A.5
  • 4
    • 0013882810 scopus 로고
    • Aetiology of coronary artery disease: An historical approach
    • Michaels L. Aetiology of coronary artery disease: an historical approach. Br Heart J 1966;28:258-64.
    • (1966) Br Heart J , vol.28 , pp. 258-264
    • Michaels, L.1
  • 5
    • 0028127942 scopus 로고
    • Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men
    • Erratum, Arterioscler Thromb 1994;14:1392
    • Heinrich J, Balleiscn L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb 1994;14:54-9. [Erratum, Arterioscler Thromb 1994;14:1392.]
    • (1994) Arterioscler Thromb , vol.14 , pp. 54-59
    • Heinrich, J.1    Balleiscn, L.2    Schulte, H.3    Assmann, G.4    Van De Loo, J.5
  • 6
    • 0023185776 scopus 로고
    • Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
    • Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2:3-9.
    • (1987) Lancet , vol.2 , pp. 3-9
    • Hamsten, A.1    De Faire, U.2    Walldius, G.3
  • 7
    • 0022485106 scopus 로고
    • Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park heart study
    • Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-7.
    • (1986) Lancet , vol.2 , pp. 533-537
    • Meade, T.W.1    Mellows, S.2    Brozovic, M.3
  • 8
    • 0028909230 scopus 로고
    • Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
    • Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
    • (1995) N Engl J Med , vol.332 , pp. 635-641
    • Thompson, S.G.1    Kienast, J.2    Pyke, S.D.M.3    Haverkate, F.4    Van De Loo, J.C.W.5
  • 9
    • 0028126597 scopus 로고
    • Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men
    • Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-40.
    • (1994) Circulation , vol.90 , pp. 2236-2240
    • Ridker, P.M.1    Hennekens, C.H.2    Cerskus, A.3    Stampfer, M.J.4
  • 10
    • 0023574958 scopus 로고
    • Plasminogen activator inhibitor 1: Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation
    • Kruithof EKO, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 1987;70:1645-53.
    • (1987) Blood , vol.70 , pp. 1645-1653
    • Kruithof, E.K.O.1    Nicolosa, G.2    Bachmann, F.3
  • 11
    • 0025992702 scopus 로고
    • Coronary thrombosis: Pathogenesis and clinical manifestations
    • Falk E. Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol 1991;68:28B-35B.
    • (1991) Am J Cardiol , vol.68
    • Falk, E.1
  • 12
    • 0024410071 scopus 로고
    • Native fibrin gel networks observed by 3D microscopy, permeation and turbidity
    • Erratum, Biochim Biophys Acta 1989;999:225
    • Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989;997:96-110. [Erratum, Biochim Biophys Acta 1989;999:225.]
    • (1989) Biochim Biophys Acta , vol.997 , pp. 96-110
    • Blombäck, B.1    Carlsson, K.2    Hessel, B.3    Liljeborg, A.4    Procyk, R.5    Aslund, N.6
  • 13
    • 0029842962 scopus 로고    scopus 로고
    • Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age
    • Fatah K, Silveira A, Tornvall P, Karpe F, Blombäck M, Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996;76:535-40.
    • (1996) Thromb Haemost , vol.76 , pp. 535-540
    • Fatah, K.1    Silveira, A.2    Tornvall, P.3    Karpe, F.4    Blombäck, M.5    Hamsten, A.6
  • 14
    • 0000413088 scopus 로고
    • The physiology and biochemistry of factor XIII
    • Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Edinburgh, Scotland: Churchill Livingstone
    • Ichinose A. The physiology and biochemistry of factor XIII. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Haemostasis and thrombosis. 3rd ed. Vol. 1. Edinburgh, Scotland: Churchill Livingstone, 1994:531-46.
    • (1994) Haemostasis and Thrombosis. 3rd Ed. , vol.1 , pp. 531-546
    • Ichinose, A.1
  • 15
    • 0032950919 scopus 로고    scopus 로고
    • The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism
    • Reed GL, Houng AK. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism. Circulation 1999;99:299-304.
    • (1999) Circulation , vol.99 , pp. 299-304
    • Reed, G.L.1    Houng, A.K.2
  • 16
    • 0025237116 scopus 로고
    • Inhibition of factor XIIIa in a canine model of coronary thrombosis: Effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator
    • Shebuski RJ, Sitko GR, Claremon DA, Baldwin JJ, Remy DC, Stern AM. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. Blood 1990;75:1455-9.
    • (1990) Blood , vol.75 , pp. 1455-1459
    • Shebuski, R.J.1    Sitko, G.R.2    Claremon, D.A.3    Baldwin, J.J.4    Remy, D.C.5    Stern, A.M.6
  • 17
    • 0023130521 scopus 로고
    • Plasminogen activator inhibitors
    • Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69:381-7.
    • (1987) Blood , vol.69 , pp. 381-387
    • Sprengers, E.D.1    Kluft, C.2
  • 19
    • 0022545062 scopus 로고
    • Blood platelet plasminogen activator inhibitor: Two different pools of endothelial cell type plasminogen activator inhibitor in human blood
    • Sprengers ED, Akkerman JWN, Jansen BG. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood. Thromb Haemost 1986;55:325-9.
    • (1986) Thromb Haemost , vol.55 , pp. 325-329
    • Sprengers, E.D.1    Akkerman, J.W.N.2    Jansen, B.G.3
  • 20
    • 0023677472 scopus 로고
    • Plasminogen activator inhibitors - A review
    • Kruithof EKO. Plasminogen activator inhibitors - a review. Enzyme 1988;40:113-21.
    • (1988) Enzyme , vol.40 , pp. 113-121
    • Kruithof, E.K.O.1
  • 21
    • 0025021029 scopus 로고
    • The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator
    • Lindahl TL, Ohlsson PI, Wiman B. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator. Biochem J 1990;265:109-13.
    • (1990) Biochem J , vol.265 , pp. 109-113
    • Lindahl, T.L.1    Ohlsson, P.I.2    Wiman, B.3
  • 22
    • 0025909612 scopus 로고
    • Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells: Evidence that the binding protein is vitronectin
    • Owensby DA, Morton PA, Wun TC, Schwartz AL. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells: evidence that the binding protein is vitronectin. J Biol Chem 1991;266: 4334-40.
    • (1991) J Biol Chem , vol.266 , pp. 4334-4340
    • Owensby, D.A.1    Morton, P.A.2    Wun, T.C.3    Schwartz, A.L.4
  • 23
    • 0022826059 scopus 로고
    • Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells
    • Kooistra T, Sprengers ED, van Hinsbergh VWH. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells. Biochem J 1986;239:497-503.
    • (1986) Biochem J , vol.239 , pp. 497-503
    • Kooistra, T.1    Sprengers, E.D.2    Van Hinsbergh, V.W.H.3
  • 24
    • 0023685082 scopus 로고
    • Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: Identification as a multimeric form of S protein (vitronectin)
    • Declerck PJ, De Mol M, Alessi MC, et al. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: identification as a multimeric form of S protein (vitronectin). J Biol Chem 1988;263:15454-61.
    • (1988) J Biol Chem , vol.263 , pp. 15454-15461
    • Declerck, P.J.1    De Mol, M.2    Alessi, M.C.3
  • 25
    • 0022599303 scopus 로고
    • Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells
    • Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986;77:165-9.
    • (1986) J Clin Invest , vol.77 , pp. 165-169
    • Gelehrter, T.D.1    Sznycer-Laszuk, R.2
  • 26
    • 0033564748 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance
    • Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999;99: 3050-5.
    • (1999) Circulation , vol.99 , pp. 3050-3055
    • Zhu, Y.1    Carmeliet, P.2    Fay, W.P.3
  • 27
    • 0020472522 scopus 로고
    • Kinetics of the activation of plasminogen by human tissue plasminogen activator: Role of fibrin
    • Hoylaerts M, Rijken DC, Lijnen HR, Collén D. Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J Biol Chem 1982;257:2912-9.
    • (1982) J Biol Chem , vol.257 , pp. 2912-2919
    • Hoylaerts, M.1    Rijken, D.C.2    Lijnen, H.R.3    Collén, D.4
  • 28
    • 0023503121 scopus 로고
    • Interaction of one-chain and two chain tissue plasminogen activator with intact and plasmin-degraded fibrin
    • Higgins DL, Vehar GA. Interaction of one-chain and two chain tissue plasminogen activator with intact and plasmin-degraded fibrin. Biochemistry 1987;26:7786-91.
    • (1987) Biochemistry , vol.26 , pp. 7786-7791
    • Higgins, D.L.1    Vehar, G.A.2
  • 29
    • 0023840635 scopus 로고
    • Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained
    • Panel R, Black J, Gurewich V. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J Clin Invest 1988;81:853-9.
    • (1988) J Clin Invest , vol.81 , pp. 853-859
    • Panel, R.1    Black, J.2    Gurewich, V.3
  • 30
    • 0024361838 scopus 로고
    • Differences between binding of one-chain and two-chain tissue plasminogen activators to non-crosslinked and cross-linked fibrin clots
    • Husain SS, Hasan AAK, Budzynski AZ. Differences between binding of one-chain and two-chain tissue plasminogen activators to non-crosslinked and cross-linked fibrin clots. Blood 1989;74:999-1006.
    • (1989) Blood , vol.74 , pp. 999-1006
    • Husain, S.S.1    Hasan, A.A.K.2    Budzynski, A.Z.3
  • 31
    • 0024311846 scopus 로고
    • Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA): Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA
    • Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA): binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. J Clin Invest 1989;84:647-55.
    • (1989) J Clin Invest , vol.84 , pp. 647-655
    • Wagner, O.F.1    De Vries, C.2    Hohmann, C.3    Veerman, H.4    Pannekoek, H.5
  • 32
    • 0026597817 scopus 로고
    • Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis
    • Levi M, Biemond BJ, van Zonneveld A-J, ten Cate JW, Pannekoek H. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 1992;85:305-12.
    • (1992) Circulation , vol.85 , pp. 305-312
    • Levi, M.1    Biemond, B.J.2    Van Zonneveld, A.-J.3    Ten Cate, J.W.4    Pannekoek, H.5
  • 33
    • 0025744035 scopus 로고
    • The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: Localization of interaction sites and physiologic relevance
    • Keijer J, Linders M, van Zonneveld AJ, Ehrlich HJ, de Boer JP, Pannekoek H. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance. Blood 1991;78:401-9.
    • (1991) Blood , vol.78 , pp. 401-409
    • Keijer, J.1    Linders, M.2    Van Zonneveld, A.J.3    Ehrlich, H.J.4    De Boer, J.P.5    Pannekoek, H.6
  • 34
    • 0032521423 scopus 로고    scopus 로고
    • Binding of tissue-plasminogen activator to fibrin: Effect of ultrasound
    • Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. Binding of tissue-plasminogen activator to fibrin: effect of ultrasound. Blood 1998;91:2019-25.
    • (1998) Blood , vol.91 , pp. 2019-2025
    • Siddiqi, F.1    Odrljin, T.M.2    Fay, P.J.3    Cox, C.4    Francis, C.W.5
  • 35
    • 0027078388 scopus 로고
    • The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis
    • Thorsen S. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis. Ann N Y Acad Sci 1992;667:52-63.
    • (1992) Ann N Y Acad Sci , vol.667 , pp. 52-63
    • Thorsen, S.1
  • 37
    • 0023855392 scopus 로고
    • Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
    • Auwerx J, Bouillon R, Collen D, Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988;8:68-72.
    • (1988) Arteriosclerosis , vol.8 , pp. 68-72
    • Auwerx, J.1    Bouillon, R.2    Collen, D.3    Geboers, J.4
  • 38
    • 0027944013 scopus 로고
    • Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke
    • Margaglione M, Di Minno G, Grandone E, et al. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 1994;14:1741-5.
    • (1994) Arterioscler Thromb , vol.14 , pp. 1741-1745
    • Margaglione, M.1    Di Minno, G.2    Grandone, E.3
  • 39
    • 0032564442 scopus 로고    scopus 로고
    • High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor
    • Thogersen AM, Jansson JH, Boman K, et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98:2241-7.
    • (1998) Circulation , vol.98 , pp. 2241-2247
    • Thogersen, A.M.1    Jansson, J.H.2    Boman, K.3
  • 40
    • 0022354051 scopus 로고
    • Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
    • Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1557-63.
    • (1985) N Engl J Med , vol.313 , pp. 1557-1563
    • Hamsten, A.1    Wiman, B.2    De Faire, U.3    Blombäck, M.4
  • 42
    • 0027441963 scopus 로고
    • Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park heart study
    • Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076-9.
    • (1993) Lancet , vol.342 , pp. 1076-1079
    • Meade, T.W.1    Ruddock, V.2    Stirling, Y.3    Chakrabarti, R.4    Miller, G.J.5
  • 43
    • 0029805074 scopus 로고    scopus 로고
    • Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
    • Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996;94:2057-63.
    • (1996) Circulation , vol.94 , pp. 2057-2063
    • Juhan-Vague, I.1    Pyke, S.D.M.2    Alessi, M.C.3    Jespersen, J.4    Haverkate, F.5    Thompson, S.G.6
  • 44
    • 0030997690 scopus 로고    scopus 로고
    • Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metroprolol: Results from the angina prognosis study in Stockholm
    • Held C, Hjemdahl P, Rehnqvist N, et al. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metroprolol: results from the Angina Prognosis Study in Stockholm. Circulation 1997;95:2380-6.
    • (1997) Circulation , vol.95 , pp. 2380-2386
    • Held, C.1    Hjemdahl, P.2    Rehnqvist, N.3
  • 45
    • 0032032320 scopus 로고    scopus 로고
    • Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function
    • Bavenholm P, de Faire U, Landou C, et al. Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. Eur Heart J 1998;19:402-10.
    • (1998) Eur Heart J , vol.19 , pp. 402-410
    • Bavenholm, P.1    De Faire, U.2    Landou, C.3
  • 46
    • 0031853098 scopus 로고    scopus 로고
    • The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes
    • Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 1998,136:109-14.
    • (1998) Atherosclerosis , vol.136 , pp. 109-114
    • Iwai, N.1    Shimoike, H.2    Nakamura, Y.3    Tamaki, S.4    Kinoshita, M.5
  • 47
    • 0032499636 scopus 로고    scopus 로고
    • Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: A potential factor predisposing to thrombosis and its persistence
    • Sobel BE, Woodcock-Mitchell J, Schneider DJ, Holt RE, Marutsuka K, Gold H. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence. Circulation 1998;97:2213-21.
    • (1998) Circulation , vol.97 , pp. 2213-2221
    • Sobel, B.E.1    Woodcock-Mitchell, J.2    Schneider, D.J.3    Holt, R.E.4    Marutsuka, K.5    Gold, H.6
  • 48
    • 0026650622 scopus 로고
    • Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries
    • Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A 1992;89:6998-7002.
    • (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 6998-7002
    • Schneiderman, J.1    Sawdey, M.S.2    Keeton, M.R.3
  • 49
    • 0030877824 scopus 로고    scopus 로고
    • Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling
    • Preissner KT, May AE, Wohn KD, Germer M, Kanse SM. Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling. Thromb Haemost 1997;78:88-95.
    • (1997) Thromb Haemost , vol.78 , pp. 88-95
    • Preissner, K.T.1    May, A.E.2    Wohn, K.D.3    Germer, M.4    Kanse, S.M.5
  • 50
    • 0029965462 scopus 로고    scopus 로고
    • Transient functional expression of alphaVbeta 3 on vascular cells during wound repair
    • Clark RAF, Tonnesen MG, Gailit J, Cheresh DA. Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. Am J Pathol 1996;148:1407-21.
    • (1996) Am J Pathol , vol.148 , pp. 1407-1421
    • Clark, R.A.F.1    Tonnesen, M.G.2    Gailit, J.3    Cheresh, D.A.4
  • 51
    • 0029745109 scopus 로고    scopus 로고
    • The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin
    • Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 1996; 383:441-3.
    • (1996) Nature , vol.383 , pp. 441-443
    • Stefansson, S.1    Lawrence, D.A.2
  • 52
    • 0030685740 scopus 로고    scopus 로고
    • Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice
    • Carmeliet P, Moors L, Lijnen R, et al. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 1997;96:3180-91.
    • (1997) Circulation , vol.96 , pp. 3180-3191
    • Carmeliet, P.1    Moors, L.2    Lijnen, R.3
  • 53
    • 0024507407 scopus 로고
    • Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)
    • Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79: 101-6.
    • (1989) Circulation , vol.79 , pp. 101-106
    • Angleton, P.1    Chandler, W.L.2    Schmer, G.3
  • 54
    • 0023770724 scopus 로고
    • Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
    • Andreotti F, Davies GJ, Hackett DR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988; 65:635-7.
    • (1988) Am J Cardiol , vol.65 , pp. 635-637
    • Andreotti, F.1    Davies, G.J.2    Hackett, D.R.3
  • 55
    • 0022206133 scopus 로고
    • Lipids, diabetes, and coronary artery disease: Insights from the Framingham study
    • Kannel WB. Lipids, diabetes, and coronary artery disease: insights from the Framingham Study. Am Heart J 1985;110:1100-7.
    • (1985) Am Heart J , vol.110 , pp. 1100-1107
    • Kannel, W.B.1
  • 56
    • 0021320254 scopus 로고
    • Ten-year incidence of coronary heart disease in the Honolulu Heart Program: Relationship to biologic and life-style characteristics
    • Yano K, Reed SM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and life-style characteristics. Am J Epidemiol 1984;119:653-66.
    • (1984) Am J Epidemiol , vol.119 , pp. 653-666
    • Yano, K.1    Reed, S.M.2    McGee, D.L.3
  • 57
    • 0025959101 scopus 로고
    • An updated coronary risk profile: A statement for health professionals
    • Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991; 83:356-62.
    • (1991) Circulation , vol.83 , pp. 356-362
    • Anderson, K.M.1    Wilson, P.W.F.2    Odell, P.M.3    Kannel, W.B.4
  • 58
    • 0024160877 scopus 로고
    • Role of insulin resistance in human disease
    • Reaven GM. Role of insulin resistance in human disease. Diabetes 1983;37:1595-607.
    • (1983) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1
  • 59
    • 0025734531 scopus 로고
    • Increased plasma plasminogen ac tivator inhibitor I levels: A possible link between insulin resistance and atherothrombosis
    • Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen ac tivator inhibitor I levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 1991;34:457-62.
    • (1991) Diabetologia , vol.34 , pp. 457-462
    • Juhan-Vague, I.1    Alessi, M.C.2    Vague, P.3
  • 60
    • 0025718469 scopus 로고
    • Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
    • Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205.
    • (1991) Atherosclerosis , vol.91 , pp. 191-205
    • Folsom, A.R.1    Wu, K.K.2    Davis, C.E.3    Conlan, M.G.4    Sorlie, P.D.5    Szklo, M.6
  • 61
    • 0028273960 scopus 로고
    • Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study
    • Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb 1994;14:686-93.
    • (1994) Arterioscler Thromb , vol.14 , pp. 686-693
    • Green, D.1    Ruth, K.J.2    Folsom, A.R.3    Liu, K.4
  • 62
    • 0018688195 scopus 로고
    • Haemostatic variables associated with diabetes and its complications
    • Fuller JH, Keen H, Jarrett RJ, et al. Haemostatic variables associated with diabetes and its complications. BMJ 1979;2:964-6.
    • (1979) BMJ , vol.2 , pp. 964-966
    • Fuller, J.H.1    Keen, H.2    Jarrett, R.J.3
  • 63
  • 64
    • 0027236046 scopus 로고
    • Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) study
    • Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380-5.
    • (1993) Thromb Haemost , vol.70 , pp. 380-385
    • Conlan, M.G.1    Folsom, A.R.2    Finch, A.3
  • 65
    • 0029851227 scopus 로고    scopus 로고
    • Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM
    • Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 1996;94: 2171-6.
    • (1996) Circulation , vol.94 , pp. 2171-2176
    • Mansfield, M.W.1    Heywood, D.M.2    Grant, P.J.3
  • 66
    • 0024327968 scopus 로고
    • Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - Relationship with plasma insulin
    • Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin. Thromb Haemost 1989;61:370-3.
    • (1989) Thromb Haemost , vol.61 , pp. 370-373
    • Juhan-Vague, I.1    Roul, C.2    Alessi, M.C.3    Ardissone, J.P.4    Heim, M.5    Vague, P.6
  • 67
    • 0029868240 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight post-menopausal women
    • Svendsen OL, Hassager C, Christiansen C, Nielsen JD, Winther K. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight post-menopausal women. Arterioscler Thromb Vasc Biol 1996;16:381-5.
    • (1996) Arterioscler Thromb Vasc Biol , vol.16 , pp. 381-385
    • Svendsen, O.L.1    Hassager, C.2    Christiansen, C.3    Nielsen, J.D.4    Winther, K.5
  • 68
    • 0029090921 scopus 로고
    • Insulin, intact and split proinsulin, and coronary artery disease in young men
    • Bavenholm P, Proudler A, Tornvall P, et al. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 1995; 92:1422-9.
    • (1995) Circulation , vol.92 , pp. 1422-1429
    • Bavenholm, P.1    Proudler, A.2    Tornvall, P.3
  • 69
    • 0027536736 scopus 로고
    • ECAT angina pectoris study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
    • ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993;14:8-17.
    • (1993) Eur Heart J , vol.14 , pp. 8-17
  • 70
    • 0026780403 scopus 로고
    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose
    • Maiello M, Boeri D, Podesta F, et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 1992;41: 1009-15.
    • (1992) Diabetes , vol.41 , pp. 1009-1015
    • Maiello, M.1    Boeri, D.2    Podesta, F.3
  • 71
    • 0029857883 scopus 로고    scopus 로고
    • Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture
    • Pandolfi A, Iacoviello L, Capani F, Vitacolonna E, Donati MB, Consoli A. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabctologia 1996;39: 1425-31.
    • (1996) Diabctologia , vol.39 , pp. 1425-1431
    • Pandolfi, A.1    Iacoviello, L.2    Capani, F.3    Vitacolonna, E.4    Donati, M.B.5    Consoli, A.6
  • 72
    • 0032478827 scopus 로고    scopus 로고
    • Sp1 sites mediate activation of the plasminogen activator inhibitor-I promoter by glucose in vascular smooth muscle cells
    • Chen YQ, Su M, Walia RR, Hao Q, Covington JW, Vaughan DE. Sp1 sites mediate activation of the plasminogen activator inhibitor-I promoter by glucose in vascular smooth muscle cells. J Biol Chem 1998;273:8225-31.
    • (1998) J Biol Chem , vol.273 , pp. 8225-8231
    • Chen, Y.Q.1    Su, M.2    Walia, R.R.3    Hao, Q.4    Covington, J.W.5    Vaughan, D.E.6
  • 73
    • 0027537594 scopus 로고
    • Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control
    • Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabet Med 1993;10:27-32.
    • (1993) Diabet Med , vol.10 , pp. 27-32
    • Jain, S.K.1    Nagi, D.K.2    Slavin, B.M.3    Lumb, P.J.4    Yudkin, J.S.5
  • 74
    • 0026651718 scopus 로고
    • Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells
    • Schneider DJ, Nordt TK, Sobel BE. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 1992;41:890-5.
    • (1992) Diabetes , vol.41 , pp. 890-895
    • Schneider, D.J.1    Nordt, T.K.2    Sobel, B.E.3
  • 75
    • 0031750031 scopus 로고    scopus 로고
    • Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes
    • Panahloo A, Mohamed-Ali V, Andrés C, Denver AE, Yudkin JS. Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes. Metabolism 1998;47:637-43.
    • (1998) Metabolism , vol.47 , pp. 637-643
    • Panahloo, A.1    Mohamed-Ali, V.2    Andrés, C.3    Denver, A.E.4    Yudkin, J.S.5
  • 76
    • 0028960526 scopus 로고
    • Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring study
    • Gebara OC, Mittleman MA, Sutherland P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995;91:1952-8.
    • (1995) Circulation , vol.91 , pp. 1952-1958
    • Gebara, O.C.1    Mittleman, M.A.2    Sutherland, P.3
  • 77
    • 0025794059 scopus 로고
    • Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension
    • Alderman MH, Madhaven S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-104.
    • (1991) N Engl J Med , vol.324 , pp. 1098-1104
    • Alderman, M.H.1    Madhaven, S.2    Ooi, W.L.3    Cohen, H.4    Sealey, J.E.5    Laragh, J.H.6
  • 78
    • 0028912882 scopus 로고
    • Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: A potential link between the renin-angiotensin system and thrombosis
    • Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: a potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995;95:995-1001.
    • (1995) J Clin Invest , vol.95 , pp. 995-1001
    • Vaughan, D.E.1    Lazos, S.A.2    Tong, K.3
  • 79
    • 0032868908 scopus 로고    scopus 로고
    • Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans
    • Brown NJ, Agirbasli M, Vaughan DE. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension 1999;34: 285-90.
    • (1999) Hypertension , vol.34 , pp. 285-290
    • Brown, N.J.1    Agirbasli, M.2    Vaughan, D.E.3
  • 80
    • 0345711546 scopus 로고    scopus 로고
    • VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: Involvement of the VLDL receptor
    • Nilsson L, Gafvels M, Musakka L, et al. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor. J Lipid Res 1999;40:913-9.
    • (1999) J Lipid Res , vol.40 , pp. 913-919
    • Nilsson, L.1    Gafvels, M.2    Musakka, L.3
  • 82
    • 0028175562 scopus 로고
    • Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells
    • Gallicchio M, Argyriou S, Ianches G, et al. Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells. Arterioscler Thromb 1994;14:815-23.
    • (1994) Arterioscler Thromb , vol.14 , pp. 815-823
    • Gallicchio, M.1    Argyriou, S.2    Ianches, G.3
  • 83
    • 0033136050 scopus 로고    scopus 로고
    • Evidence that hepirin but not hirudin reduces PAI-1 expression in cultured human endothelial cells
    • Orbe J, Montes R, Zabalegui N, Pérez-Ruiz A, Paramo JA. Evidence that hepirin but not hirudin reduces PAI-1 expression in cultured human endothelial cells. Thromb Res 1999;94:137-45.
    • (1999) Thromb Res , vol.94 , pp. 137-145
    • Orbe, J.1    Montes, R.2    Zabalegui, N.3    Pérez-Ruiz, A.4    Paramo, J.A.5
  • 84
    • 0023812882 scopus 로고
    • The organization of the human-plasminogen-activator-inhibitor-1 gene: Implications on the evolution of the serine-protease inhibitor family
    • Strandberg L, Lawrence D, Ny T. The organization of the human-plasminogen-activator-inhibitor-1 gene: implications on the evolution of the serine-protease inhibitor family. Eur J Biochem 1988;176:609-16.
    • (1988) Eur J Biochem , vol.176 , pp. 609-616
    • Strandberg, L.1    Lawrence, D.2    Ny, T.3
  • 85
    • 0026016865 scopus 로고
    • Genetic variation at the plasminogen activator-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity
    • Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1991;11:183-90.
    • (1991) Arterioscler Thromb , vol.11 , pp. 183-190
    • Dawson, S.1    Hamsten, A.2    Wiman, B.3    Henney, A.4    Humphries, S.5
  • 86
    • 0023478914 scopus 로고
    • Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis
    • Klinger KW, Winqvist R, Riccio A, et al. Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Natl Acad Sci U S A 1987;84: 8548-52.
    • (1987) Proc Natl Acad Sci U S A , vol.84 , pp. 8548-8552
    • Klinger, K.W.1    Winqvist, R.2    Riccio, A.3
  • 87
    • 0027311245 scopus 로고
    • The two allele sequences of a common polymorphism in the promoter of the plasminogen activator-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells
    • Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993;268:10739-45.
    • (1993) J Biol Chem , vol.268 , pp. 10739-10745
    • Dawson, S.J.1    Wiman, B.2    Hamsten, A.3    Green, F.4    Humphries, S.5    Henney, A.M.6
  • 88
    • 0028901713 scopus 로고
    • Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
    • Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851-5.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 1851-1855
    • Eriksson, P.1    Kallin, B.2    Van 'T Hooft, F.M.3    Bavenholm, P.4    Hamsten, A.5
  • 89
    • 0029084141 scopus 로고
    • Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus
    • Mansfield MW, Stickland MH, Grant PJ. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost 1995;74:842-7.
    • (1995) Thromb Haemost , vol.74 , pp. 842-847
    • Mansfield, M.W.1    Stickland, M.H.2    Grant, P.J.3
  • 90
    • 0031963391 scopus 로고    scopus 로고
    • Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia
    • Eriksson P, Nilsson L, Karpe F, Hamsten A. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1998;18:20-6.
    • (1998) Arterioscler Thromb Vasc Biol , vol.18 , pp. 20-26
    • Eriksson, P.1    Nilsson, L.2    Karpe, F.3    Hamsten, A.4
  • 91
    • 0030059836 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL
    • Sironi L, Mussoni L, Prati L, et al. Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. Arterioscler Thromb Vasc Biol 1996;16:89-96.
    • (1996) Arterioscler Thromb Vasc Biol , vol.16 , pp. 89-96
    • Sironi, L.1    Mussoni, L.2    Prati, L.3
  • 92
    • 0028882653 scopus 로고
    • Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes
    • Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995;74:1032-4.
    • (1995) Thromb Haemost , vol.74 , pp. 1032-1034
    • Mansfield, M.W.1    Stickland, M.H.2    Grant, P.J.3
  • 93
    • 0031028790 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography
    • Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography Arterioscler Thromb Vasc Biol 1997;17:33-7.
    • (1997) Arterioscler Thromb Vasc Biol , vol.17 , pp. 33-37
    • Ossei-Gerning, N.1    Mansfield, M.W.2    Stickland, M.H.3    Wilson, I.J.4    Grant, P.J.5
  • 94
    • 0031862628 scopus 로고    scopus 로고
    • The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease
    • Margaglione M, Cappucci G, Colaizzo D, et al. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:152-6.
    • (1998) Arterioscler Thromb Vasc Biol , vol.18 , pp. 152-156
    • Margaglione, M.1    Cappucci, G.2    Colaizzo, D.3
  • 95
    • 0029124975 scopus 로고
    • The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study
    • Ye S, Green FR, Scarabin PY, et al. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 1995;74:837-41.
    • (1995) Thromb Haemost , vol.74 , pp. 837-841
    • Ye, S.1    Green, F.R.2    Scarabin, P.Y.3
  • 96
    • 0031016432 scopus 로고    scopus 로고
    • Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men
    • Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 1997;95:59-62.
    • (1997) Circulation , vol.95 , pp. 59-62
    • Ridker, P.M.1    Hennekens, C.H.2    Lindpaintner, K.3    Stampfer, M.J.4    Miletich, J.P.5
  • 97
    • 0032873136 scopus 로고    scopus 로고
    • The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphisms is associated with coronary atherosclerosis in patients at high risk for this disease
    • Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphisms is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost 1999;82:1121-6.
    • (1999) Thromb Haemost , vol.82 , pp. 1121-1126
    • Gardemann, A.1    Lohre, J.2    Katz, N.3    Tillmanns, H.4    Hehrlein, F.W.5    Haberbosch, W.6
  • 98
    • 0030966138 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease
    • Catto AJ, Carter AM, Stickland M, Bamford JM, Davies JA, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 1997;77:730-4.
    • (1997) Thromb Haemost , vol.77 , pp. 730-734
    • Catto, A.J.1    Carter, A.M.2    Stickland, M.3    Bamford, J.M.4    Davies, J.A.5    Grant, P.J.6
  • 101
    • 0032588857 scopus 로고    scopus 로고
    • Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
    • Wartiovaara U, Perola M, Mikkola H, et al. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999;142:295-300.
    • (1999) Atherosclerosis , vol.142 , pp. 295-300
    • Wartiovaara, U.1    Perola, M.2    Mikkola, H.3
  • 103
    • 0032845075 scopus 로고    scopus 로고
    • Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease
    • Kohler HP, Mansfield MW, Clark PS, Grant PJ. Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease. Thromb Haemost 1999;82:1202-3.
    • (1999) Thromb Haemost , vol.82 , pp. 1202-1203
    • Kohler, H.P.1    Mansfield, M.W.2    Clark, P.S.3    Grant, P.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.